undefined

S6-04 PATIENT-REPORTED OUTCOME (PRO) RESULTS, NRG ONCOLOGY/NSABP B-35: A CLINICAL TRIAL OF ANASTROZOLE (A) VS TAMOXIFEN (TAM) IN POSTMENOPAUSAL PATIENTS WITH DCIS UNDERGOING LUMPECTOMY PLUS RADIOTHERAPYSpeaker: Patricia A Ganz

Slide 1 / 28

Slide 2 / 28

Page 1

undefined

S6-04 PATIENT-REPORTED OUTCOME (PRO) RESULTS, NRG ONCOLOGY/NSABP B-35: A CLINICAL TRIAL OF ANASTROZOLE (A) VS TAMOXIFEN (TAM) IN POSTMENOPAUSAL PATIENTS WITH DCIS UNDERGOING LUMPECTOMY PLUS RADIOTHERAPYSpeaker: Patricia A Ganz

Slide 3 / 28

Slide 4 / 28

Page 2

undefined

S6-04 PATIENT-REPORTED OUTCOME (PRO) RESULTS, NRG ONCOLOGY/NSABP B-35: A CLINICAL TRIAL OF ANASTROZOLE (A) VS TAMOXIFEN (TAM) IN POSTMENOPAUSAL PATIENTS WITH DCIS UNDERGOING LUMPECTOMY PLUS RADIOTHERAPYSpeaker: Patricia A Ganz

Slide 5 / 28

Slide 6 / 28

Page 3

undefined

S6-04 PATIENT-REPORTED OUTCOME (PRO) RESULTS, NRG ONCOLOGY/NSABP B-35: A CLINICAL TRIAL OF ANASTROZOLE (A) VS TAMOXIFEN (TAM) IN POSTMENOPAUSAL PATIENTS WITH DCIS UNDERGOING LUMPECTOMY PLUS RADIOTHERAPYSpeaker: Patricia A Ganz

Slide 7 / 28

Slide 8 / 28

Page 4

undefined

S6-04 PATIENT-REPORTED OUTCOME (PRO) RESULTS, NRG ONCOLOGY/NSABP B-35: A CLINICAL TRIAL OF ANASTROZOLE (A) VS TAMOXIFEN (TAM) IN POSTMENOPAUSAL PATIENTS WITH DCIS UNDERGOING LUMPECTOMY PLUS RADIOTHERAPYSpeaker: Patricia A Ganz

Slide 9 / 28

Slide 10 / 28

Page 5

undefined

S6-04 PATIENT-REPORTED OUTCOME (PRO) RESULTS, NRG ONCOLOGY/NSABP B-35: A CLINICAL TRIAL OF ANASTROZOLE (A) VS TAMOXIFEN (TAM) IN POSTMENOPAUSAL PATIENTS WITH DCIS UNDERGOING LUMPECTOMY PLUS RADIOTHERAPYSpeaker: Patricia A Ganz

Slide 11 / 28

Slide 12 / 28

Page 6

undefined

S6-04 PATIENT-REPORTED OUTCOME (PRO) RESULTS, NRG ONCOLOGY/NSABP B-35: A CLINICAL TRIAL OF ANASTROZOLE (A) VS TAMOXIFEN (TAM) IN POSTMENOPAUSAL PATIENTS WITH DCIS UNDERGOING LUMPECTOMY PLUS RADIOTHERAPYSpeaker: Patricia A Ganz

Slide 13 / 28

Slide 14 / 28

Page 7

undefined

S6-04 PATIENT-REPORTED OUTCOME (PRO) RESULTS, NRG ONCOLOGY/NSABP B-35: A CLINICAL TRIAL OF ANASTROZOLE (A) VS TAMOXIFEN (TAM) IN POSTMENOPAUSAL PATIENTS WITH DCIS UNDERGOING LUMPECTOMY PLUS RADIOTHERAPYSpeaker: Patricia A Ganz

Slide 15 / 28

Slide 16 / 28

Page 8

undefined

S6-04 PATIENT-REPORTED OUTCOME (PRO) RESULTS, NRG ONCOLOGY/NSABP B-35: A CLINICAL TRIAL OF ANASTROZOLE (A) VS TAMOXIFEN (TAM) IN POSTMENOPAUSAL PATIENTS WITH DCIS UNDERGOING LUMPECTOMY PLUS RADIOTHERAPYSpeaker: Patricia A Ganz

Slide 17 / 28

Slide 18 / 28

Page 9

undefined

S6-04 PATIENT-REPORTED OUTCOME (PRO) RESULTS, NRG ONCOLOGY/NSABP B-35: A CLINICAL TRIAL OF ANASTROZOLE (A) VS TAMOXIFEN (TAM) IN POSTMENOPAUSAL PATIENTS WITH DCIS UNDERGOING LUMPECTOMY PLUS RADIOTHERAPYSpeaker: Patricia A Ganz

Slide 19 / 28

Slide 20 / 28

Page 10

undefined

S6-04 PATIENT-REPORTED OUTCOME (PRO) RESULTS, NRG ONCOLOGY/NSABP B-35: A CLINICAL TRIAL OF ANASTROZOLE (A) VS TAMOXIFEN (TAM) IN POSTMENOPAUSAL PATIENTS WITH DCIS UNDERGOING LUMPECTOMY PLUS RADIOTHERAPYSpeaker: Patricia A Ganz

Slide 21 / 28

Slide 22 / 28

Page 11

undefined

S6-04 PATIENT-REPORTED OUTCOME (PRO) RESULTS, NRG ONCOLOGY/NSABP B-35: A CLINICAL TRIAL OF ANASTROZOLE (A) VS TAMOXIFEN (TAM) IN POSTMENOPAUSAL PATIENTS WITH DCIS UNDERGOING LUMPECTOMY PLUS RADIOTHERAPYSpeaker: Patricia A Ganz

Slide 23 / 28

Slide 24 / 28

Page 12

undefined

S6-04 PATIENT-REPORTED OUTCOME (PRO) RESULTS, NRG ONCOLOGY/NSABP B-35: A CLINICAL TRIAL OF ANASTROZOLE (A) VS TAMOXIFEN (TAM) IN POSTMENOPAUSAL PATIENTS WITH DCIS UNDERGOING LUMPECTOMY PLUS RADIOTHERAPYSpeaker: Patricia A Ganz

Slide 25 / 28

Slide 26 / 28

Page 13

undefined

S6-04 PATIENT-REPORTED OUTCOME (PRO) RESULTS, NRG ONCOLOGY/NSABP B-35: A CLINICAL TRIAL OF ANASTROZOLE (A) VS TAMOXIFEN (TAM) IN POSTMENOPAUSAL PATIENTS WITH DCIS UNDERGOING LUMPECTOMY PLUS RADIOTHERAPYSpeaker: Patricia A Ganz

Slide 27 / 28

Slide 28 / 28

Page 14